Notable Labs, Ltd. (NTBLQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jun 20, 2025, 4:00 PM EDT

Notable Labs Company Description

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive medicines for patients with cancer.

The company, through its proprietary Predictive Precision Medicines Platform (PMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.

Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population.

The company’s pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox to treat acute myeloid leukemia.

It has a license agreement with Oncoheroes to develop and commercialize volasertib for cancers not licensed to the Company.

Notable Labs, Ltd. is based in Foster City, California. On October 13, 2024, Notable Labs, Ltd. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

It is in joint administration with Notable Labs, Inc.

Notable Labs, Ltd.
Country Israel
Founded 2014
Industry Biotechnology
Sector Healthcare
Employees 16
CEO Kaile Zagger

Contact Details

Address:
320 Hatch Drive
Foster City, 94404
United States
Phone 415 851 2410
Website notablelabs.com

Stock Details

Ticker Symbol NTBLQ
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number IL0012002452
SIC Code 2836

Key Executives

Name Position
Kaile Zagger Interim Chief Executive Officer and Chief Restructuring Officer
Scott Alan McPherson CFE, CPA, CVA Chief Financial Officer
Dr. Joseph P. Wagner Ph.D. Chief Scientific Officer
Dr. Glenn C. Michelson M.D. Chief Medical Officer